Guizhou Yibai Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 600594?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	16,948,653	2.15%
Institutions	19,809,057	2.52%
Individual Insiders	199,564,905	25.4%
General Public	550,567,385	70%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 30.03% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23.6%	Qiling Dou	185,457,636	CN¥686.2m	0%	no data
2.15%	Guangzhou City Construnction Investment Group	16,948,653	CN¥62.7m	0%	no data
1.01%	Hong Ping Lang	7,912,009	CN¥29.3m	0%	no data
0.88%	Gfund Management Co., Ltd.	6,936,800	CN¥25.7m	0%	0.11%
0.54%	UBS Asset Management AG	4,233,508	CN¥15.7m	0%	no data
0.52%	Ning Gan	4,102,660	CN¥15.2m	0%	no data
0.44%	CITIC Securities Company Limited, Asset Management Arm	3,472,115	CN¥12.8m	0%	0.02%
0.27%	China Universal Asset Management Company Ltd.	2,142,900	CN¥7.9m	0%	no data
0.23%	Zhiwei Wang	1,800,000	CN¥6.7m	0%	no data
0.1%	The Vanguard Group, Inc.	806,800	CN¥3.0m	0%	no data
0.095%	Wanjia Asset Management Co., Ltd.	746,600	CN¥2.8m	0%	no data
0.094%	Everbright Pramerica Fund Management Co. Ltd.	738,000	CN¥2.7m	0%	0.03%
0.033%	Ya Qi Dou	263,400	CN¥974.5k	0%	no data
0.018%	Huatai-PineBridge Fund Management Co., Ltd.	138,910	CN¥513.9k	0%	no data
0.015%	Nuode Asset Management Co., Ltd.	118,124	CN¥437.0k	0%	no data
0.015%	China Southern Asset Management Co., Ltd.	115,900	CN¥428.9k	0%	no data
0.011%	Yinhua Fund Management Co., Ltd.	86,400	CN¥319.7k	0%	no data
0.0081%	Manulife Asset Management	63,400	CN¥234.7k	0%	no data
0.0056%	China Asset Management Co. Ltd.	44,300	CN¥163.9k	0%	no data
0.005%	Bank of China Investment Management Co., Ltd.	39,700	CN¥147.0k	0%	no data
0.0044%	Invesco Great Wall Fund Management Co. Ltd	34,900	CN¥129.3k	0%	no data
0.0039%	ICBC Credit Suisse Asset Management Co., Ltd.	30,900	CN¥114.4k	0%	no data
0.0033%	Fullgoal Fund Management Co. Ltd.	26,200	CN¥97.0k	0%	no data
0.0025%	E Fund Management Co., Ltd.	19,700	CN¥72.8k	0%	no data
0.0019%	Tao Jiang	15,000	CN¥55.6k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 02:42
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guizhou Yibai Pharmaceutical Co., Ltd. is covered by 20 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Shuchang Liu	Changjiang Securities Co. LTD.
Chi Man Wong	China Galaxy International Securities (Hong Kong)
Haigang Chen	China International Capital Corporation Limited